Skip to content

Veracyte VCYT Amortization of acquired technology

Amortization of acquired technology at other companies

Independent Bank Corp logo
Independent Bank CorpINDB
$4.23M+186%
Open Text logo
Open TextOTEX
$43.32M-8.2%
Veracyte logo
VeracyteVCYT
$2.71M+4.7%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$8.1M-1.9%
Willis Towers Watson logo
Willis Towers WatsonWTW
$48M0.0%
Dynatrace logo
DynatraceDT
$927K+26.3%

Segments

By segment

See full
Reportable Segment$2.71M+4.7%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.28B+10.7%
Enterprise value$4.05B+7.4%
P/E48.6×-68.3×
P/S7.9×-0.4×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldAmortization.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's amortization of acquired technology.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's amortization of acquired technology?
Veracyte (VCYT) reported amortization of acquired technology of $2.71M in Q1 2026.
How has Veracyte's amortization of acquired technology changed year-over-year?
Veracyte's amortization of acquired technology increased by 4.7% year-over-year, from $2.59M to $2.71M.
What is the long-term trend for Veracyte's amortization of acquired technology?
Over 3 years (2022 to 2025), Veracyte's amortization of acquired technology has grown at a -17.9% compound annual growth rate (CAGR), from $19.27M to $10.67M.
What does amortization of acquired technology mean?
This represents the non-cash expense related to the systematic allocation of the cost of acquired intangible assets, such as patents or proprietary technology, over their estimated useful lives. It reflects the consumption of economic value from previously acquired intellectual property used in the production of goods or services. Investors monitor this to distinguish between operational production costs and the accounting recognition of historical acquisition investments.